Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares

CANFAMEXUSD
2.92 USD
0.05 (1.75%)🟢PRE MARKET (AS OF 06:38 AM EDT)
🟢Market: OPEN
Open?$3.01
High?$3.07
Low?$2.91
Prev. Close?$2.92
Volume?2.0K
Avg. Volume?N/A
VWAP?$2.97
Bid / Ask
Bid?$2.91 × 1.2K
Ask?$3.03 × 800
Spread?$0.12
Midpoint?$2.97
Valuation & Ratios
Market Cap?6.3M
Shares Out?2.1M
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Related Companies
Loading...
News
Profile
Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.
Employees
5
Market Cap
6.3M
Industry
N/A
Listed
2012-09-10